We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MNOV market cap is 95.64M. The company's latest EPS is USD -0.1748 and P/E is -11.21.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1M | 0 | 0 | 0 | 0 |
| Operating Income | -1.15M | -2.49M | -3.14M | -3.05M | -3.31M |
| Net Income | -723k | -2.06M | -2.76M | -2.63M | -2.85M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 4.04M | 0 | 1M |
| Operating Income | -14.03M | -14.18M | -10.22M | -14.63M | -9.9M |
| Net Income | -12.94M | -13.85M | -10.13M | -14.07M | -8.57M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 68.14M | 66.27M | 62.89M | 60.4M | 58.12M |
| Total Liabilities | 3.47M | 3.89M | 3.06M | 3M | 3.05M |
| Total Equity | 64.67M | 62.38M | 59.83M | 57.41M | 55.07M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 79.21M | 75.42M | 87.41M | 74.16M | 66.27M |
| Total Liabilities | 4.31M | 4.09M | 3.73M | 3.91M | 3.89M |
| Total Equity | 74.9M | 71.33M | 83.68M | 70.24M | 62.38M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.93M | -7.43M | -3.87M | -6.68M | -8.71M |
| Investing | 39.91M | 39.91M | N/A | -1,000 | -1,000 |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.13M | -10.83M | -9.38M | -12.91M | -7.43M |
| Investing | -11k | -36k | -29k | -40.01M | 39.91M |
| Financing | 10.62M | 7.11M | 20.78M | 8k | N/A |
| Market Cap | 95.64M |
| Price to Earnings Ratio | -11.21 |
| Price to Sales Ratio | 96.08 |
| Price to Cash Ratio | 1.88 |
| Price to Book Ratio | 1.54 |
| Dividend Yield | - |
| Shares Outstanding | 49.05M |
| Average Volume (1 week) | 48.24k |
| Average Volume (1 Month) | 52.92k |
| 52 Week Change | 34.48% |
| 52 Week High | 2.55 |
| 52 Week Low | 1.12 |
| Spread (Intraday) | 0.11 (5.34%) |
| Company Name | Medicinova Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.medicinova.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
